Who has invested in Nuclein?

Trinity Private Equity Group are named among the investors backing Nuclein.

Nuclein Funding: $20M Raised, Series B (2021)

Nuclein funding overview

Nuclein is based in Austin. Nuclein has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Nuclein runs through 2021; nothing later has been disclosed. Investors on record include Trinity Private Equity Group.

Nuclein at a glance

Total raised: $20M
Latest round: Series B
Latest round date: March 2021
Headquarters: Austin
Notable investors: Trinity Private Equity Group

Frequently asked about Nuclein funding

How much has Nuclein raised?: Nuclein has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Nuclein?: Trinity Private Equity Group are named among the investors backing Nuclein.
What was the latest Nuclein funding round?: The most recent disclosed round is a Series B, announced in March 2021.
Where is Nuclein based?: Nuclein is based in Austin.
When did Nuclein last raise?: The last disclosed Nuclein round closed in March 2021 at Series B.

Nuclein totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Austin below to benchmark round size and investor mix.

Nuclein Funding: $20M Raised, Series B (2021)

Nuclein funding overview

Nuclein at a glance

Frequently asked about Nuclein funding

Companies related to Nuclein (19)

Browse related funding lists (5)